Retina Society 2023: Experimental study of evaporative heavy liquids for retinal tamponade
October 13th 2023Retina Society
The investigators performed clinical examinations and obtained fundus photographs and inferior optical coherence tomography (OCT) images for both treatments at baseline and on days 1, 3, 8, 15, and 56 after the injections.
EURETINA 2023: Safety and efficacy through week 48 in the Phase 2a STARLIGHT clinical trial
October 6th 2023EURETINA
We spoke with Michael Singer, MD who provided an overview of his presentation and his work with Nanoscope Therapeutics, "MCO-010 Optogenetic Therapy to Treat Stargardt Disease: Safety and Efficacy through Week 48 in the Phase 2a STARLIGHT Clinical Trial."